Streetbeat News

Regulatory

SPY

Federal Reserve's John Williams has suggested that it would be sensible to slow down on rate rises given the current economic conditions. This could potentially impact the performance of the SPY ETF.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:24 pm

SPY

Federal Reserve's Williams stated that inflation expectations have been 'remarkably well anchored'. He also mentioned that the Fed still has work to do to balance demand and supply. He fully supported the Fed's decision to hold steady on rates at the June FOMC meeting.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 8:23 pm

SPY

Federal Reserve Bank of New York President John Williams stated that the ultimate fate of inflation is in the hands of the Federal Reserve. This statement suggests that the Fed has the power to control inflation rates through its monetary policies.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 8:21 pm

SPY

Federal Reserve Bank of New York President John Williams expressed surprise at the stability of the natural rate of interest, which has remained steady despite the economic turmoil caused by the pandemic. This could influence the Fed's future monetary policy decisions.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:17 pm

SPY

Federal Reserve's John Williams stated that it may take a year or two to feel the peak effect of monetary policy. This statement could influence the market's expectations about the pace of future interest rate hikes.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:16 pm

SPY

Federal Reserve's John Williams expressed surprise at the resilience of the housing market amidst the pandemic. He did not mention any specific stocks or ETFs.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:13 pm

VSTM

Verastem Oncology has finalized the design of its Phase 3 trial for the combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer. The trial, RAMP 301, will commence in the second half of 2023. The company also intends to file for accelerated FDA approval based on data from RAMP 201 and the FRAME trial. As of March 31, 2023, Verastem had cash and short-term investments of $111.2M, which increased to approximately $202.7M after a public offering in June 2023.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:11 pm

CBUS

Cibus, Inc. (NASDAQ:CBUS), an agricultural technology company, has welcomed the European Commission's proposal on the regulation of plants obtained from New Genomic Techniques (NGTs). The proposal aims to adapt EU legislation to scientific and technological progress, enabling NGTs to contribute to sustainable agriculture, climate resilience, and food security. The proposed regulation identifies a 'Conventional-like' category of NGT products that would be regulated as conventional varieties. Products from Cibus' gene editing platform, such as canola and oilseed rape resistant to disease or with reduced seed losses, would be considered 'Conventional-like'.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:10 pm

SPY

Federal Reserve's John Williams expressed dissatisfaction with the current state of inflation, emphasizing that combating inflation remains the Fed's primary responsibility.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:08 pm

JBLU

JetBlue has issued a statement disagreeing with the court's ruling against its Northeast Alliance (NEA) with American Airlines. The company believes the NEA has been successful in increasing capacity, adding new routes, reducing fares, and providing an alternative to Delta and United. The alliance has also expanded the value of JetBlue's loyalty program benefits.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 8:08 pm